Burdensome health care spending in the United States is a wide-reaching issue that requires multiple solutions, according to an expert.Adam Gaffney, MD, MPH, an assistant professor of medicine at Harvard Medical School, and colleagues recently publishe…
Fear of needles is one of health care’s most common, and most ignored, barriers.Millions of people experience anxiety or panic attacks at just the sight of a syringe. Some avoid routine vaccinations or postpone blood tests or IV treatments until sympto…
The FDA approved Yuvezzi, an eye drop for the treatment of presbyopia, with broad U.S. availability expected in the second quarter, according to a press release from Tenpoint Therapeutics.Yuvezzi (carbachol 2.75%/brimonidine tartrate 0.1% ophthalmic so…
LONDON–(BUSINESS WIRE)– #aiml–Automata, the lab automation company building fully integrated, AI-ready platforms for life sciences, today announced the close of a $45 million Series C funding round led by Dimension with participation from Danaher Ve…
Diabetes patients on tirzepatide have lower risks for new or worsening diabetic retinopathy, eye complications, and the need for eye treatments than those relying on lifestyle interventions alone. Medscape Medical News
LONDON & SEATTLE–(BUSINESS WIRE)–Tenpoint Therapeutics, Ltd., a global, commercial biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the aging eye, today announced it has secured $235 million through the su…